Saturday, March 31, 2018 11:20:52 AM
Meanwhile a PR campaign logically should initiate. Tell us about manufacturing, U of Maryland success, GSA and government sales beginning; incremental revenues and retail rollout plans.
Hopefully tell us about funding package to get phase 2 clinicals rolling for MS pediatric. Tell us if you plan to pursue government grants and funding that is coming available to fight opiods. These funds could be all that is needed to strengthen Nyloxin case as a significant tool to fight pain, etc..
Nobody is denying the product, nor the potential. We just need a methodical structured approach and watch market valuations quickly rise to 20,30,50 million as success is achieved. Whether there is 2,2.5, or 3 Billion shares out won’t matter much as the stock surpasses .01 and sales and clinical pipelines have momentum. Optimism will be high and 100 or 200 million valuations will seem and realistically be more achievable in the following year..
Everyone wins: the company, the financiers, shareholders and most importantly the people who desperately need real solutions to medical issues.
Be methodical.. be patient.. be successful..
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM